Compare Hims and Hers Health Inc (HIMS) vs United Airlines Holdings Inc (UAL) Price & Performance

Hims & Hers Health (HIMS) trades at $29.38, down 0.54% on the day, amid a bearish technical signal and mixed earnings history. The company reported revenue of $2.35 billion in 2025 with a net income of $128.37 million, but 2026 projections show a net loss of $142 million. Valuation ratios are elevated with a P/E of 57.14 and EV/EBITDA of 205.86. Recent news highlights multiple securities class action lawsuits filed against the company, creating investor uncertainty.

The outlook is cautious due to profitability concerns and legal risks. Analyst consensus is a Hold with a $32.17 price target, suggesting limited upside. Key risks include ongoing litigation, negative profit margins, and high valuation multiples. Investment appeal hinges on the company's ability to return to profitability and navigate regulatory challenges.

United Airlines (UAL) trades at $105.65, down 4.1% today, with a bearish technical signal despite recent earnings beats. The company shows solid fundamentals with revenue growth from $57.1B in 2024 to $59.1B in 2025 and net income of $3.35B. Valuation metrics appear attractive with P/E of 10.06 and P/S of 0.56. Recent news highlights aggressive customer acquisition strategies targeting Delta and American Airlines' premium travelers with status-match offers and Starlink-enabled WiFi advantages.

The investment outlook remains positive given strong analyst consensus (66% buy rating) with $158.10 price target representing 50% upside. Key risks include rising fuel costs, labor expenses, and competitive pressures. Earnings momentum continues with three consecutive quarterly beats, though Q3 2026 results will be crucial for maintaining investor confidence amid current technical weakness.